Sign in
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
Journal article   Open access  Peer reviewed

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

M. Hiligsmann and J.-Y. Reginster
Osteoporosis international, Vol.30(3), pp.649-658
01/03/2019
PMCID: PMC6423313
PMID: 30701342

Abstract

Cost-effectiveness Economic evaluation Original Osteoporosis Risedronate Treatment
url
https://doi.org/10.1007/s00198-018-04821-7View
Published (Version of record) Open

Metrics

1 Record Views

Details